Security key
45779A846
InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR)
CUSIP: 45779A846
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 10,178,288
- Total 13F value
- $23,962,111
- Share change
- -161,156
- Put/Call ratio
- 0.8%
- SEC-reported price per share
- $2.37
- Number of holders
- 25
- Value change
- -$399,400
- Number of buys
- 3
- Number of sells
- 6
- Shares outstanding
- 48,244,715
Holder snapshot
7 signals
Show 1 more signal
Security identity
Who this page is about.
1 source field
Report period
Q1 2024
Institutions
25
Top holders
10
NSPR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
InspireMD, Inc. SEC filings
InspireMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45779A846
Recent filing periods:
Ownership snapshot
Top reported holders of NSPR - InspireMD, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 4.4%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 4.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
4.4%
Nantahala Capital Management, LLC
4.3%
MARSHALL WACE, LLP
3.9%
Soleus Capital Management, L.P.
2.9%
Rosalind Advisors, Inc.
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
4.4%
|
$5,994,868
2,133,405 shares
|
— | 31 Dec 2023 |
| Nantahala Capital Management, LLC |
13F
Company
|
4.3%
|
$5,806,742
2,066,456 shares
|
— | 31 Dec 2023 |
| MARSHALL WACE, LLP |
13F
Company
|
3.9%
|
$5,227,738
1,860,405 shares
|
— | 31 Dec 2023 |
| Soleus Capital Management, L.P. |
13F
Company
|
2.9%
|
$3,872,540
1,378,128 shares
|
— | 31 Dec 2023 |
| Rosalind Advisors, Inc. |
13F
Company
|
1.9%
|
$2,599,795
925,194 shares
|
— | 31 Dec 2023 |
| Velan Capital Investment Management LP |
13F
Company
|
1.9%
|
$2,540,321
904,029 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
10,178,288
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
27
Q1 2024 holders
25
Holder diff
-2
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend